{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:09:13Z","timestamp":1789430953492,"version":"build-2803163510"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"University of Otago Doctoral Scholarship"},{"name":"McGee Fellowship"},{"name":"Heart Foundation100 Fellowship"},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["20-538"],"award-info":[{"award-number":["20-538"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001543","name":"Neurological Foundation of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001543","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sir Charles Hercus Career Development Fellowship of the Health Research Council of New Zealand","award":["17-039"],"award-info":[{"award-number":["17-039"]}]},{"name":"New Zealand Brain Research Institute"},{"DOI":"10.13039\/501100009477","name":"Lottery Health Research","doi-asserted-by":"publisher","award":["72620"],"award-info":[{"award-number":["72620"]}],"id":[{"id":"10.13039\/501100009477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008247","name":"University of Otago","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008247","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01276-0","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:16:48Z","timestamp":1770967008000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Altered cerebrovascular haemodynamics in Parkinson\u2019s disease: Insights from 4D flow MRI"],"prefix":"10.1038","volume":"12","author":[{"given":"Ashley R.","family":"Deane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Myall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pilbrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Shoorangiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Grenfell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Goulden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Sharifzadeh-Kermani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross J.","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Dalrymple-Alford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy R.","family":"Melzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"1276_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1498756","volume":"16","author":"Y Luo","year":"2025","unstructured":"Luo, Y. et al. Global, regional, national epidemiology and trends of Parkinson\u2019s disease from 1990 to 2021: findings from the Global Burden of Disease Study 2021. Front. Aging Neurosci. 16, 1498756 (2025).","journal-title":"Front. Aging Neurosci."},{"key":"1276_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely, M. A., Reid, W. G. J., Adena, M. A., Halliday, G. M. & Morris, J. G. L. The Sydney Multicenter Study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov. Disord. 23, 837\u2013844 (2008).","journal-title":"Mov. Disord."},{"key":"1276_CR3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209699","volume":"103","author":"J Gallagher","year":"2024","unstructured":"Gallagher, J. et al. Long-term dementia risk in Parkinson disease. Neurology 103, e209699 (2024).","journal-title":"Neurology"},{"key":"1276_CR4","first-page":"1","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland, D. et al. Parkinson disease-associated cognitive impairment. Nat. Rev. Dis. Prim. 7, 1\u201321 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1276_CR5","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.neuron.2023.03.021","volume":"111","author":"M Carceles-Cordon","year":"2023","unstructured":"Carceles-Cordon, M., Weintraub, D. & Chen-Plotkin, A. S. Cognitive heterogeneity in Parkinson\u2019s disease: a mechanistic view. Neuron 111, 1531\u20131546 (2023).","journal-title":"Neuron"},{"key":"1276_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/psyp.13796","volume":"58","author":"B Zimmerman","year":"2021","unstructured":"Zimmerman, B., Rypma, B., Gratton, G. & Fabiani, M. Age-related changes in cerebrovascular health and their effects on neural function and cognition: a comprehensive review. Psychophysiology 58, 1\u201339 (2021).","journal-title":"Psychophysiology"},{"key":"1276_CR7","first-page":"1234","volume":"90","author":"C Smith","year":"2019","unstructured":"Smith, C. et al. Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies. J. Neurol. Neurosurg. Psychiatry 90, 1234\u20131243 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1276_CR8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/mds.27991","volume":"35","author":"MG Knox","year":"2020","unstructured":"Knox, M. G. et al. Neuropathological findings in Parkinson\u2019s disease with mild cognitive impairment. Mov. Disord. 35, 845\u2013850 (2020).","journal-title":"Mov. Disord."},{"key":"1276_CR9","first-page":"2076942","volume":"2020","author":"C Fang","year":"2020","unstructured":"Fang, C., Lv, L., Mao, S., Dong, H. & Liu, B. Cognition deficits in Parkinson\u2019s disease: mechanisms and treatment. Parkinsons Dis. 2020, 2076942 (2020).","journal-title":"Parkinsons Dis."},{"key":"1276_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/npjparkd.2016.18","volume":"2","author":"R Biundo","year":"2016","unstructured":"Biundo, R., Weis, L. & Antonini, A. Cognitive decline in Parkinson\u2019s disease: the complex picture. npj Parkinsons Dis. 2, 1\u20137 (2016).","journal-title":"npj Parkinsons Dis."},{"key":"1276_CR11","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00702-019-02003-1","volume":"126","author":"S Martinez-Horta","year":"2019","unstructured":"Martinez-Horta, S. & Kulisevsky, J. Mild cognitive impairment in Parkinson\u2019s disease. J. Neural Transm. 126, 897\u2013904 (2019).","journal-title":"J. Neural Transm."},{"key":"1276_CR12","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/ene.14076","volume":"27","author":"M Alves","year":"2020","unstructured":"Alves, M., Caldeira, D., Ferro, J. M. & Ferreira, J. J. Does Parkinson\u2019s disease increase the risk of cardiovascular events? A systematic review and meta-analysis. Eur. J. Neurol. 27, 288\u2013296 (2020).","journal-title":"Eur. J. Neurol."},{"key":"1276_CR13","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/acn3.732","volume":"6","author":"J Kizza","year":"2019","unstructured":"Kizza, J. et al. Cardiovascular risk factors and Parkinson\u2019s disease in 500,000 Chinese adults. Ann. Clin. Transl. Neurol. 6, 624\u2013632 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1276_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-72549-y","volume":"14","author":"S Lim","year":"2024","unstructured":"Lim, S. et al. Cardiovascular outcomes in Parkinson\u2019s disease patients from a retrospective cohort study. Sci. Rep. 14, 21928 (2024).","journal-title":"Sci. Rep."},{"key":"1276_CR15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.119.044948","volume":"141","author":"J-H Park","year":"2020","unstructured":"Park, J.-H. et al. Association of Parkinson disease with risk of cardiovascular disease and all-cause mortality: a nationwide, population-based cohort study. Circulation 141, 1205\u20131207 (2020).","journal-title":"Circulation"},{"key":"1276_CR16","doi-asserted-by":"publisher","first-page":"100986","DOI":"10.1016\/j.bbih.2025.100986","volume":"45","author":"MF Georgescu","year":"2025","unstructured":"Georgescu, M. F. et al. Cardiovascular health and its association with dementia, Parkinson\u2019s disease, and mortality among UK older adults. Brain Behav. Immun. Health 45, 100986 (2025).","journal-title":"Brain Behav. Immun. Health"},{"key":"1276_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-024-02200-2","volume":"23","author":"L Ke","year":"2024","unstructured":"Ke, L., Zhao, L., Xing, W. & Tang, Q. Association between Parkinson\u2019s disease and cardiovascular disease mortality: a prospective population-based study from NHANES. Lipids Health Dis. 23, 212 (2024).","journal-title":"Lipids Health Dis."},{"key":"1276_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mi.2024.194","volume":"4","author":"I Khalil","year":"2024","unstructured":"Khalil, I. et al. Cardiovascular dysautonomia and cognitive impairment in Parkinson\u2019s disease (Review). Med. Int. 4, 1\u201317 (2024).","journal-title":"Med. Int."},{"key":"1276_CR19","doi-asserted-by":"publisher","first-page":"525","DOI":"10.5603\/PJNNS.a2021.0040","volume":"55","author":"M Kwa\u015bniak-Butowska","year":"2021","unstructured":"Kwa\u015bniak-Butowska, M. et al. Cardiovascular dysautonomia and cognition in Parkinson\u2019s Disease \u2014 a possible relationship. Neurol. Neurochirurgia Pol. 55, 525\u2013535 (2021).","journal-title":"Neurol. Neurochirurgia Pol."},{"key":"1276_CR20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/ene.13797","volume":"26","author":"LM Chahine","year":"2018","unstructured":"Chahine, L. M. et al. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson\u2019s disease. Eur. J. Neurol. 26, 246\u2013e18 (2018).","journal-title":"Eur. J. Neurol."},{"key":"1276_CR21","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/gps.4735","volume":"33","author":"M Doiron","year":"2018","unstructured":"Doiron, M., Langlois, M., Dupr\u00e9, N. & Simard, M. The influence of vascular risk factors on cognitive function in early Parkinson\u2019s disease. Int. J. Geriatr. Psychiatry 33, 288\u2013297 (2018).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"1276_CR22","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/mds.26698","volume":"31","author":"N Malek","year":"2016","unstructured":"Malek, N. et al. Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson\u2019s disease. Mov. Disord. 31, 1518\u20131526 (2016).","journal-title":"Mov. Disord."},{"key":"1276_CR23","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/mds.27665","volume":"34","author":"Y Guo","year":"2019","unstructured":"Guo, Y. et al. Modifiable risk factors for cognitive impairment in Parkinson\u2019s disease: a systematic review and meta-analysis of prospective cohort studies. Mov. Disord. 34, 876\u2013883 (2019).","journal-title":"Mov. Disord."},{"key":"1276_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1212\/WNL.0000000000003452","volume":"88","author":"J Centi","year":"2017","unstructured":"Centi, J. et al. Effects of orthostatic hypotension on cognition in Parkinson disease. Neurology 88, 17\u201324 (2017).","journal-title":"Neurology"},{"key":"1276_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/mds.27492","volume":"34","author":"B Mollenhauer","year":"2019","unstructured":"Mollenhauer, B. et al. Baseline predictors for progression 4 years after Parkinson\u2019s disease diagnosis in the De Novo Parkinson Cohort (DeNoPa). Mov. Disord. 34, 67\u201377 (2019).","journal-title":"Mov. Disord."},{"key":"1276_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3233\/JAD-150610","volume":"51","author":"A Pilotto","year":"2016","unstructured":"Pilotto, A. et al. Vascular risk factors and cognition in Parkinson\u2019s disease. J. Alzheimers. Dis. 51, 563\u2013570 (2016).","journal-title":"J. Alzheimers. Dis."},{"key":"1276_CR27","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/ejcn.2014.259","volume":"69","author":"M Vikdahl","year":"2015","unstructured":"Vikdahl, M., B\u00e4ckman, L., Johansson, I., Forsgren, L. & H\u00e5glin, L. Cardiovascular risk factors and the risk of Parkinson\u2019s disease. Eur. J. Clin. Nutr. 69, 729\u2013733 (2015).","journal-title":"Eur. J. Clin. Nutr."},{"key":"1276_CR28","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/j.acra.2022.11.001","volume":"30","author":"D Joshi","year":"2023","unstructured":"Joshi, D., Prasad, S., Saini, J. & Ingalhalikar, M. Role of arterial spin labeling (ASL) images in Parkinson\u2019s disease (PD): a systematic review. Acad. Radiol. 30, 1695\u20131708 (2023).","journal-title":"Acad. Radiol."},{"key":"1276_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.parkreldis.2020.12.025","volume":"83","author":"H Chen","year":"2021","unstructured":"Chen, H. et al. Cerebral small vessel disease may worsen motor function, cognition, and mood in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 83, 86\u201392 (2021).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1276_CR30","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1002\/mds.27798","volume":"34","author":"YW Park","year":"2019","unstructured":"Park, Y. W. et al. Magnetic resonance imaging\u2013visible perivascular spaces in Basal Ganglia predict cognitive decline in Parkinson\u2019s disease. Mov. Disord. 34, 1672\u20131679 (2019).","journal-title":"Mov. Disord."},{"key":"1276_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.clineuro.2019.04.029","volume":"182","author":"K Shibata","year":"2019","unstructured":"Shibata, K., Sugiura, M., Nishimura, Y. & Sakura, H. The effect of small vessel disease on motor and cognitive function in Parkinson\u2019s disease. Clin. Neurol. Neurosurg. 182, 58\u201362 (2019).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"1276_CR32","doi-asserted-by":"crossref","unstructured":"Si, X. et al. Different perivascular space burdens in idiopathic rapid eye movement sleep behavior disorder and Parkinson\u2019s disease. Front. Aging Neurosci. 12, 580853 (2020).","DOI":"10.3389\/fnagi.2020.580853"},{"key":"1276_CR33","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.parkreldis.2013.03.008","volume":"19","author":"N Kandiah","year":"2013","unstructured":"Kandiah, N. et al. Cerebral white matter hyperintensity in Parkinson\u2019s disease: a major risk factor for mild cognitive impairment. Parkinsonism Relat. Disord. 19, 680\u2013683 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1276_CR34","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.nicl.2018.09.025","volume":"20","author":"M Dadar","year":"2018","unstructured":"Dadar, M. et al. White matter hyperintensities are linked to future cognitive decline in de novo Parkinson\u2019s disease patients. NeuroImage: Clin. 20, 892\u2013900 (2018).","journal-title":"NeuroImage: Clin."},{"key":"1276_CR35","unstructured":"Cipolla, M. J. The Cerebral Circulation, 2nd ed. (Morgan & Claypool Life Sciences, 2016)."},{"key":"1276_CR36","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1177\/0271678X15617952","volume":"36","author":"EA Warnert","year":"2016","unstructured":"Warnert, E. A., Hart, E. C., Hall, J. E., Murphy, K. & Wise, R. G. The major cerebral arteries proximal to the Circle of Willis contribute to cerebrovascular resistance in humans. J. Cereb. Blood Flow. Metab. 36, 1384\u20131395 (2016).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1276_CR37","doi-asserted-by":"publisher","unstructured":"Traystman, R. J. Chapter 1 - Cerebrovascular Anatomy and Hemodynamics. In Primer on Cerebrovascular Diseases (Second Edition) (eds. Caplan, L. R. et al.) 5\u201312 https:\/\/doi.org\/10.1016\/B978-0-12-803058-5.00001-1 (Academic Press, San Diego, 2017).","DOI":"10.1016\/B978-0-12-803058-5.00001-1"},{"key":"1276_CR38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/joim.13392","volume":"291","author":"A W\u00e5hlin","year":"2022","unstructured":"W\u00e5hlin, A., Eklund, A. & Malm, J. 4D flow MRI hemodynamic biomarkers for cerebrovascular diseases. J. Intern. Med. 291, 115\u2013127 (2022).","journal-title":"J. Intern. Med."},{"key":"1276_CR39","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.crad.2016.01.011","volume":"71","author":"M Markl","year":"2016","unstructured":"Markl, M. et al. Advanced flow MRI: emerging techniques and applications. Clin. Radiol. 71, 779\u2013795 (2016).","journal-title":"Clin. Radiol."},{"key":"1276_CR40","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1177\/0271678X15617171","volume":"36","author":"LA Rivera-Rivera","year":"2016","unstructured":"Rivera-Rivera, L. A. et al. 4D flow MRI for intracranial hemodynamics assessment in Alzheimer\u2019s disease. J. Cereb. Blood Flow. Metab. 36, 1718\u20131730 (2016).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1276_CR41","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1177\/0271678X16661340","volume":"37","author":"LA Rivera-Rivera","year":"2017","unstructured":"Rivera-Rivera, L. A. et al. Changes in intracranial venous blood flow and pulsatility in Alzheimer\u2019s disease: a 4D flow MRI study. J. Cereb. Blood Flow. Metab. 37, 2149\u20132158 (2017).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1276_CR42","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1177\/0271678X20910302","volume":"41","author":"LA Rivera-Rivera","year":"2021","unstructured":"Rivera-Rivera, L. A. et al. Assessment of vascular stiffness in the internal carotid artery proximal to the carotid canal in Alzheimer\u2019s disease using pulse wave velocity from low rank reconstructed 4D flow MRI. J. Cereb. Blood Flow. Metab. 41, 298\u2013311 (2021).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1276_CR43","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.222685","volume":"307","author":"GS Roberts","year":"2023","unstructured":"Roberts, G. S. et al. Normative cerebral hemodynamics in middle-aged and older adults using 4D flow MRI: initial analysis of vascular aging. Radiology 307, e222685 (2023).","journal-title":"Radiology"},{"key":"1276_CR44","first-page":"420","volume":"1","author":"SE Berman","year":"2015","unstructured":"Berman, S. E. et al. Intracranial arterial four-dimensional flow is associated with metrics of brain health and Alzheimer\u2019s disease. Alzheimers. Dement. 1, 420\u2013428 (2015).","journal-title":"Alzheimers. Dement."},{"key":"1276_CR45","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3233\/JAD-170402","volume":"60","author":"SE Berman","year":"2017","unstructured":"Berman, S. E. et al. Intracranial arterial 4D flow in individuals with mild cognitive impairment is associated with cognitive performance and amyloid positivity. J. Alzheimers. Dis. 60, 243\u2013252 (2017).","journal-title":"J. Alzheimers. Dis."},{"key":"1276_CR46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.parkreldis.2020.02.019","volume":"73","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. Vascular, flow and perfusion abnormalities in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 73, 8\u201313 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1276_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1353-8020(98)00020-0","volume":"4","author":"NM Bornstein","year":"1998","unstructured":"Bornstein, N. M., Halevy, G., Treves, T. & Korczyn, A. D. Cerebral atherosclerosis in Parkinsonian patients. Parkinsonism Relat. Disord. 4, 87\u201390 (1998).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1276_CR48","first-page":"523041","volume":"2015","author":"CHF Camargo","year":"2015","unstructured":"Camargo, C. H. F. et al. Abnormal cerebrovascular reactivity in patients with Parkinson\u2019s disease. Parkinsons. Dis. 2015, 523041 (2015).","journal-title":"Parkinsons. Dis."},{"key":"1276_CR49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jns.2006.12.017","volume":"254","author":"N Vokatch","year":"2007","unstructured":"Vokatch, N., Gr\u00f6tzsch, H., Mermillod, B., Burkhard, P. R. & Sztajzel, R. Is cerebral autoregulation impaired in Parkinson\u2019s disease? A transcranial Doppler study. J. Neurol. Sci. 254, 49\u201353 (2007).","journal-title":"J. Neurol. Sci."},{"key":"1276_CR50","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2147\/NDT.S358150","volume":"18","author":"Y-L Ge","year":"2022","unstructured":"Ge, Y.-L. et al. Cognitive performance is associated with altered cerebral hemodynamics assessed by transcranial ultrasound in Parkinson\u2019s disease. Neuropsychiatr. Dis. Treat. 18, 1421\u20131431 (2022).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"1276_CR51","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.parkreldis.2008.02.007","volume":"15","author":"I Rektor","year":"2009","unstructured":"Rektor, I. et al. Vascular pathology in patients with idiopathic Parkinson\u2019s disease. Parkinsonism Relat. Disord. 15, 24\u201329 (2009).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1276_CR52","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/brain\/awq377","volume":"134","author":"TR Melzer","year":"2011","unstructured":"Melzer, T. R. et al. Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson\u2019s disease. Brain 134, 845\u2013855 (2011).","journal-title":"Brain"},{"key":"1276_CR53","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1016\/j.neuroimage.2011.10.033","volume":"59","author":"MA Fern\u00e1ndez-Seara","year":"2012","unstructured":"Fern\u00e1ndez-Seara, M. A. et al. Cortical hypoperfusion in Parkinson\u2019s disease assessed using arterial spin labeled perfusion MRI. Neuroimage 59, 2743\u20132750 (2012).","journal-title":"Neuroimage"},{"key":"1276_CR54","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S1053-8119(03)00364-1","volume":"20","author":"MJ Firbank","year":"2003","unstructured":"Firbank, M. J., Colloby, S. J., Burn, D. J., McKeith, I. G. & O\u2019Brien, J. T. Regional cerebral blood flow in Parkinson\u2019s disease with and without dementia. Neuroimage 20, 1309\u20131319 (2003).","journal-title":"Neuroimage"},{"key":"1276_CR55","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/jmri.22515","volume":"33","author":"K Kamagata","year":"2011","unstructured":"Kamagata, K. et al. Posterior hypoperfusion in Parkinson\u2019s disease with and without dementia measured with arterial spin labeling MRI. J. Magn. Reson. Imaging 33, 803\u2013807 (2011).","journal-title":"J. Magn. Reson. Imaging"},{"key":"1276_CR56","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3389\/fneur.2020.00562","volume":"11","author":"L Pelizzari","year":"2020","unstructured":"Pelizzari, L. et al. Parietal perfusion alterations in Parkinson\u2019s disease patients without dementia. Front. Neurol. 11, 562 (2020).","journal-title":"Front. Neurol."},{"key":"1276_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12880-020-00479-y","volume":"20","author":"L Cheng","year":"2020","unstructured":"Cheng, L. et al. Discriminative pattern of reduced cerebral blood flow in Parkinson\u2019s disease and Parkinsonism-Plus syndrome: an ASL-MRI study. BMC Med. Imaging 20, 1\u20139 (2020).","journal-title":"BMC Med. Imaging"},{"key":"1276_CR58","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.nicl.2014.06.007","volume":"5","author":"LK Teune","year":"2014","unstructured":"Teune, L. K. et al. Parkinson\u2019s disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging. NeuroImage Clin. 5, 240\u2013244 (2014).","journal-title":"NeuroImage Clin."},{"key":"1276_CR59","doi-asserted-by":"publisher","first-page":"848","DOI":"10.2967\/jnumed.111.089946","volume":"52","author":"NI Bohnen","year":"2011","unstructured":"Bohnen, N. I. et al. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. J. Nucl. Med. 52, 848\u2013855 (2011).","journal-title":"J. Nucl. Med."},{"key":"1276_CR60","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s00259-012-2198-5","volume":"39","author":"D Garcia-Garcia","year":"2012","unstructured":"Garcia-Garcia, D. et al. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson\u2019s disease. Eur. J. Nucl. Med. Mol. Imaging 39, 1767\u20131777 (2012).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"1276_CR61","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1093\/brain\/awu159","volume":"137","author":"R Gonzalez-Redondo","year":"2014","unstructured":"Gonzalez-Redondo, R. et al. Grey matter hypometabolism and atrophy in Parkinson\u2019s disease with cognitive impairment: a two-step process. Brain 137, 2356\u20132367 (2014).","journal-title":"Brain"},{"key":"1276_CR62","doi-asserted-by":"publisher","first-page":"46","DOI":"10.17116\/jnevro20171175146-51","volume":"117","author":"JG Homenko","year":"2017","unstructured":"Homenko, J. G., Susin, D., Kataeva, G., Irishina, J. A. & Zavolokov, I. Characteristics of cerebral glucose metabolism in patients with cognitive impairment in Parkinson\u2019s disease. Zh. Nevrol. Psikhiatr. Im. SS Korsakova 117, 46\u201351 (2017).","journal-title":"Zh. Nevrol. Psikhiatr. Im. SS Korsakova"},{"key":"1276_CR63","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet 397, 2284\u20132303 (2021).","journal-title":"Lancet"},{"key":"1276_CR64","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/ejn.14094","volume":"49","author":"JC Greenland","year":"2019","unstructured":"Greenland, J. C., Williams-Gray, C. H. & Barker, R. A. The clinical heterogeneity of Parkinson\u2019s disease and its therapeutic implications. Eur. J. Neurosci. 49, 328\u2013338 (2019).","journal-title":"Eur. J. Neurosci."},{"key":"1276_CR65","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3233\/JAD-2009-1079","volume":"17","author":"JAHR Claassen","year":"2009","unstructured":"Claassen, J. A. H. R., Diaz-Arrastia, R., Martin-Cook, K., Levine, B. D. & Zhang, R. Altered cerebral hemodynamics in early Alzheimer disease: a pilot study using transcranial Doppler. J. Alzheimers. Dis. 17, 621\u2013629 (2009).","journal-title":"J. Alzheimers. Dis."},{"key":"1276_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.811698","volume":"13","author":"Y Xing","year":"2022","unstructured":"Xing, Y. et al. Impaired cerebral autoregulation in Parkinson\u2019s disease: an orthostatic hypotension analysis. Front. Neurol. 13, 811698 (2022).","journal-title":"Front. Neurol."},{"key":"1276_CR67","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.parkreldis.2015.10.018","volume":"21","author":"E Indelicato","year":"2015","unstructured":"Indelicato, E. et al. Cerebral autoregulation and white matter lesions in Parkinson\u2019s disease and multiple system atrophy. Parkinsonism Relat. Disord. 21, 1393\u20131397 (2015).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1276_CR68","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.parkreldis.2022.01.002","volume":"95","author":"H Chen","year":"2022","unstructured":"Chen, H. et al. Perivascular space in Parkinson\u2019s disease: association with CSF amyloid\/tau and cognitive decline. Parkinsonism Relat. Disord. 95, 70\u201376 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1276_CR69","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10286-018-00584-7","volume":"29","author":"JM Metzger","year":"2019","unstructured":"Metzger, J. M. & Emborg, M. E. Autonomic dysfunction in Parkinson disease and animal models. Clin. Autonomic Res. 29, 397\u2013414 (2019).","journal-title":"Clin. Autonomic Res."},{"key":"1276_CR70","doi-asserted-by":"publisher","first-page":"626640","DOI":"10.3389\/fphys.2021.626640","volume":"12","author":"JL Sabino-Carvalho","year":"2021","unstructured":"Sabino-Carvalho, J. L., Fisher, J. P. & Vianna, L. C. Autonomic function in patients with Parkinson\u2019s disease: from rest to exercise. Front. Physiol. 12, 626640 (2021).","journal-title":"Front. Physiol."},{"key":"1276_CR71","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/mds.870110308","volume":"11","author":"EM Gatto","year":"1996","unstructured":"Gatto, E. M. et al. Neutrophil function, nitric oxide, and blood oxidative stress in Parkinson\u2019s disease. Mov. Disord. 11, 261\u2013267 (1996).","journal-title":"Mov. Disord."},{"key":"1276_CR72","unstructured":"Sanyal, J. et al. Plasma level of nitrates in patients with Parkinson\u2019s disease in West Bengal. Neurol. Asia 15, 87\u201389 (2010)."},{"key":"1276_CR73","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/mds.29429","volume":"38","author":"SG Ryman","year":"2023","unstructured":"Ryman, S. G. et al. Reduced and delayed cerebrovascular reactivity in patients with Parkinson\u2019s disease. Mov. Disord. 38, 1262\u20131272 (2023).","journal-title":"Mov. Disord."},{"key":"1276_CR74","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.clineuro.2010.12.014","volume":"113","author":"B Zamani","year":"2011","unstructured":"Zamani, B., Mehrabani, M., Fereshtehnejad, S.-M. & Rohani, M. Evaluation of cerebral vasomotor reactivity in Parkinson\u2019s disease: Is there any association with orthostatic hypotension? Clin. Neurol. Neurosurg. 113, 368\u2013372 (2011).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"1276_CR75","doi-asserted-by":"crossref","unstructured":"Prell, T. et al. Sicca symptoms in Parkinson\u2019s disease: association with other nonmotor symptoms and health-related quality of life. Parkinsons Dis. 2020, 2958635 (2020).","DOI":"10.1155\/2020\/2958635"},{"key":"1276_CR76","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.14336\/AD.2021.0214","volume":"12","author":"S Zhu","year":"2021","unstructured":"Zhu, S. et al. The pathogenesis and treatment of cardiovascular autonomic dysfunction in Parkinson\u2019s disease: what we know and where to go. Aging Dis. 12, 1675 (2021).","journal-title":"Aging Dis."},{"key":"1276_CR77","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cger.2019.09.002","volume":"36","author":"J-A Palma","year":"2019","unstructured":"Palma, J.-A. & Kaufmann, H. Orthostatic hypotension in Parkinson disease. Clin. Geriatr. Med. 36, 53 (2019).","journal-title":"Clin. Geriatr. Med."},{"key":"1276_CR78","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1056\/NEJMra1509723","volume":"382","author":"H Kaufmann","year":"2020","unstructured":"Kaufmann, H., Norcliffe-Kaufmann, L. & Palma, J.-A. Baroreflex dysfunction. N. Engl. J. Med. 382, 163\u2013178 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1276_CR79","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1212\/WNL.0000000000002086","volume":"85","author":"DS Goldstein","year":"2015","unstructured":"Goldstein, D. S., Holmes, C., Sharabi, Y. & Wu, T. Survival in synucleinopathies: a prospective cohort study. Neurology 85, 1554\u20131561 (2015).","journal-title":"Neurology"},{"key":"1276_CR80","doi-asserted-by":"crossref","unstructured":"Lin, W.-C. et al. Autonomic function impairment and brain perfusion deficit in Parkinson\u2019s disease. Front. Neurol. 8, 246 (2017).","DOI":"10.3389\/fneur.2017.00246"},{"key":"1276_CR81","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/jnnp-2012-303135","volume":"84","author":"M Asahina","year":"2013","unstructured":"Asahina, M., Vichayanrat, E., Low, D. A., Iodice, V. & Mathias, C. J. Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology. J. Neurol. Neurosurg. Psychiatry 84, 674\u2013680 (2013).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1276_CR82","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/bpa.12769","volume":"30","author":"Y Hase","year":"2020","unstructured":"Hase, Y. et al. Small vessel disease pathological changes in neurodegenerative and vascular dementias concomitant with autonomic dysfunction. Brain Pathol. 30, 191\u2013202 (2020).","journal-title":"Brain Pathol."},{"key":"1276_CR83","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/jmri.27903","volume":"55","author":"Y Xiong","year":"2022","unstructured":"Xiong, Y. et al. Effects of levodopa therapy on cerebral arteries and perfusion in Parkinson\u2019s disease patients. J. Magn. Reson. Imaging 55, 943\u2013953 (2022).","journal-title":"J. Magn. Reson. Imaging"},{"key":"1276_CR84","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.parkreldis.2020.05.014","volume":"76","author":"S Rane","year":"2020","unstructured":"Rane, S. et al. Arterial spin labeling detects perfusion patterns related to motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 76, 21\u201328 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1276_CR85","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cortex.2019.01.016","volume":"115","author":"P Trujillo","year":"2019","unstructured":"Trujillo, P. et al. Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson\u2019s disease. Cortex 115, 99\u2013111 (2019).","journal-title":"Cortex"},{"key":"1276_CR86","doi-asserted-by":"publisher","first-page":"e1381","DOI":"10.7717\/peerj.1381","volume":"3","author":"Y Chen","year":"2015","unstructured":"Chen, Y., Pressman, P., Simuni, T., Parrish, T. B. & Gitelman, D. R. Effects of acute levodopa challenge on resting cerebral blood flow in Parkinson\u2019s Disease patients assessed using pseudo-continuous arterial spin labeling. PeerJ 3, e1381 (2015).","journal-title":"PeerJ"},{"key":"1276_CR87","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/mds.26128","volume":"30","author":"TM Madhyastha","year":"2015","unstructured":"Madhyastha, T. M. et al. Cerebral perfusion and cortical thickness indicate cortical involvement in mild Parkinson\u2019s disease. Mov. Disord. 30, 1893\u20131900 (2015).","journal-title":"Mov. Disord."},{"key":"1276_CR88","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00234-022-03085-7","volume":"65","author":"Y Kitazaki","year":"2023","unstructured":"Kitazaki, Y. et al. Regional cortical hypoperfusion and atrophy correlate with striatal dopaminergic loss in Parkinson\u2019s disease: a study using arterial spin labeling MR perfusion. Neuroradiology 65, 569\u2013577 (2023).","journal-title":"Neuroradiology"},{"key":"1276_CR89","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jns.2011.09.010","volume":"313","author":"P Borghammer","year":"2012","unstructured":"Borghammer, P. et al. Cerebral oxygen metabolism in patients with early Parkinson\u2019s disease. J. Neurol. Sci. 313, 123\u2013128 (2012).","journal-title":"J. Neurol. Sci."},{"key":"1276_CR90","doi-asserted-by":"publisher","first-page":"188 LP","DOI":"10.1136\/jnnp-2011-300828","volume":"83","author":"TR Melzer","year":"2012","unstructured":"Melzer, T. R. et al. Grey matter atrophy in cognitively impaired Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 83, 188 LP\u2013188194 (2012).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1276_CR91","doi-asserted-by":"publisher","first-page":"e2231189","DOI":"10.1001\/jamanetworkopen.2022.31189","volume":"5","author":"M Bouhrara","year":"2022","unstructured":"Bouhrara, M. et al. Association of cerebral blood flow with longitudinal changes in cerebral microstructural integrity in the coronary artery risk development in young adults (CARDIA) study. JAMA Netw. Open 5, e2231189\u2013e2231189 (2022).","journal-title":"JAMA Netw. Open"},{"key":"1276_CR92","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/jmri.28508","volume":"58","author":"M Kiely","year":"2023","unstructured":"Kiely, M. et al. Evidence of an association between cerebral blood flow and microstructural integrity in normative aging using a holistic MRI approach. J. Magn. Reson. Imaging 58, 284\u2013293 (2023).","journal-title":"J. Magn. Reson. Imaging"},{"key":"1276_CR93","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1177\/0271678X16688919","volume":"37","author":"S Al-Bachari","year":"2017","unstructured":"Al-Bachari, S., Vidyasagar, R., Emsley, H. C. & Parkes, L. M. Structural and physiological neurovascular changes in idiopathic Parkinson\u2019s disease and its clinical phenotypes. J. Cereb. Blood Flow. Metab. 37, 3409\u20133421 (2017).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1276_CR94","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrneurol.2009.136","volume":"5","author":"W Nanhoe-Mahabier","year":"2009","unstructured":"Nanhoe-Mahabier, W. et al. Parkinson disease and comorbid cerebrovascular disease. Nat. Rev. Neurol. 5, 533\u2013541 (2009).","journal-title":"Nat. Rev. Neurol."},{"key":"1276_CR95","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.3390\/ijms22094958","volume":"22","author":"F Paolini Paoletti","year":"2021","unstructured":"Paolini Paoletti, F., Simoni, S., Parnetti, L. & Gaetani, L. The contribution of small vessel disease to neurodegeneration: focus on Alzheimer\u2019s disease, Parkinson\u2019s disease and multiple sclerosis. Int. J. Mol. Sci. 22, 4958 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1276_CR96","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jocn.2018.10.029","volume":"58","author":"RS Schwartz","year":"2018","unstructured":"Schwartz, R. S., Halliday, G. M., Soh, D., Cordato, D. J. & Kril, J. J. Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson\u2019s disease. J. Clin. Neurosci. 58, 70\u201374 (2018).","journal-title":"J. Clin. Neurosci."},{"key":"1276_CR97","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1152\/physrev.00022.2020","volume":"101","author":"JAHR Claassen","year":"2021","unstructured":"Claassen, J. A. H. R., Thijssen, D. H. J., Panerai, R. B. & Faraci, F. M. Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation. Physiol. Rev. 101, 1487\u20131559 (2021).","journal-title":"Physiol. Rev."},{"key":"1276_CR98","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s12576-017-0525-0","volume":"67","author":"S Ogoh","year":"2017","unstructured":"Ogoh, S. Relationship between cognitive function and regulation of cerebral blood flow. J. Physiol. Sci. 67, 345\u2013351 (2017).","journal-title":"J. Physiol. Sci."},{"key":"1276_CR99","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.tins.2022.08.004","volume":"45","author":"PJ Drew","year":"2022","unstructured":"Drew, P. J. Neurovascular coupling: motive unknown. Trends Neurosci. 45, 809\u2013819 (2022).","journal-title":"Trends Neurosci."},{"key":"1276_CR100","doi-asserted-by":"publisher","first-page":"6859","DOI":"10.1073\/pnas.111164398","volume":"98","author":"MA Mintun","year":"2001","unstructured":"Mintun, M. A. et al. Blood flow and oxygen delivery to human brain during functional activity: theoretical modeling and experimental data. Proc. Natl. Acad. Sci. 98, 6859\u20136864 (2001).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"1276_CR101","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/jmri.10111","volume":"15","author":"KS St Lawrence","year":"2002","unstructured":"St Lawrence, K. S. et al. Effects of indomethacin on cerebral blood flow at rest and during hypercapnia: an arterial spin tagging study in humans. J. Magn. Reson. Imaging 15, 628\u2013635 (2002).","journal-title":"J. Magn. Reson. Imaging"},{"key":"1276_CR102","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0304-3940(96)13210-9","volume":"220","author":"P Schumann","year":"1996","unstructured":"Schumann, P. et al. Effects of indomethacin on cerebral blood flow and oxygen metabolism: a positron emission tomographic investigation in the anaesthetized baboon. Neurosci. Lett. 220, 137\u2013141 (1996).","journal-title":"Neurosci. Lett."},{"key":"1276_CR103","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuroimage.2007.10.049","volume":"40","author":"JE Perthen","year":"2008","unstructured":"Perthen, J. E., Lansing, A. E., Liau, J., Liu, T. T. & Buxton, R. B. Caffeine-induced uncoupling of cerebral blood flow and oxygen metabolism: a calibrated BOLD fMRI study. Neuroimage 40, 237\u2013247 (2008).","journal-title":"Neuroimage"},{"key":"1276_CR104","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neuroimage.2015.01.046","volume":"110","author":"F Xu","year":"2015","unstructured":"Xu, F., Liu, P., Pekar, J. J. & Lu, H. Does acute caffeine ingestion alter brain metabolism in young adults? Neuroimage 110, 39\u201347 (2015).","journal-title":"Neuroimage"},{"key":"1276_CR105","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1113\/JP280118","volume":"599","author":"L Shoemaker","year":"2021","unstructured":"Shoemaker, L. et al. Indomethacin markedly blunts cerebral perfusion and reactivity, with little cognitive consequence in healthy young and older adults. J. Physiol. 599, 1097\u20131113 (2021).","journal-title":"J. Physiol."},{"key":"1276_CR106","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1002\/hbm.20732","volume":"30","author":"MA Addicott","year":"2009","unstructured":"Addicott, M. A. et al. The effect of daily caffeine use on cerebral blood flow: how much caffeine can we tolerate? Hum. Brain Mapp. 30, 3102\u20133114 (2009).","journal-title":"Hum. Brain Mapp."},{"key":"1276_CR107","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/01616412.1999.11740964","volume":"21","author":"RS Slavik","year":"1999","unstructured":"Slavik, R. S. & Rhoney, D. H. Indomethacin: a review of its cerebral blood flow effects and potential use for controlling intracranial pressure in traumatic brain injury patients. Neurological Res. 21, 491\u2013499 (1999).","journal-title":"Neurological Res."},{"key":"1276_CR108","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/mrm.28677","volume":"86","author":"SH Pahlavian","year":"2021","unstructured":"Pahlavian, S. H. et al. Assessment of carotid stiffness by measuring carotid pulse wave velocity using a single-slice oblique-sagittal phase-contrast MRI. Magn. Reson. Med. 86, 442\u2013455 (2021).","journal-title":"Magn. Reson. Med."},{"key":"1276_CR109","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s11892-007-0043-1","volume":"7","author":"MLG Correia","year":"2007","unstructured":"Correia, M. L. G. & Haynes, W. G. Arterial compliance and endothelial function. Curr. Diab. Rep. 7, 269\u2013275 (2007).","journal-title":"Curr. Diab. Rep."},{"key":"1276_CR110","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1161\/STROKEAHA.112.655837","volume":"43","author":"AJS Webb","year":"2012","unstructured":"Webb, A. J. S. et al. Increased cerebral arterial pulsatility in patients with leukoaraiosis. Stroke 43, 2631\u20132636 (2012).","journal-title":"Stroke"},{"key":"1276_CR111","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1161\/STROKEAHA.121.035560","volume":"53","author":"AJS Webb","year":"2022","unstructured":"Webb, A. J. S. et al. Aortic stiffness, pulse pressure, and cerebral pulsatility progress despite best medical management: the OXVASC cohort. Stroke 53, 1310\u20131317 (2022).","journal-title":"Stroke"},{"key":"1276_CR112","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1093\/brain\/awr253","volume":"134","author":"GF Mitchell","year":"2011","unstructured":"Mitchell, G. F. et al. Arterial stiffness, pressure and flow pulsatility and brain structure and function: the age, gene\/environment susceptibility \u2013 Reykjavik study. Brain 134, 3398\u20133407 (2011).","journal-title":"Brain"},{"key":"1276_CR113","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/jcbfm.2014.44","volume":"34","author":"T Tarumi","year":"2014","unstructured":"Tarumi, T. et al. Cerebral hemodynamics in normal aging: central artery stiffness, wave reflection, and pressure pulsatility. J. Cereb. Blood Flow. Metab. 34, 971\u2013978 (2014).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1276_CR114","doi-asserted-by":"publisher","first-page":"H1214","DOI":"10.1152\/ajpheart.00637.2017","volume":"314","author":"N Thorin-Trescases","year":"2018","unstructured":"Thorin-Trescases, N. et al. Impact of pulse pressure on cerebrovascular events leading to age-related cognitive decline. Am. J. Physiol. Heart Circ. Physiol. 314, H1214\u2013H1224 (2018).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1276_CR115","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/j.2040-4603.2014.tb00557.x","volume":"4","author":"DS Goldstein","year":"2014","unstructured":"Goldstein, D. S. Dysautonomia in Parkinson\u2019s disease: neurocardiological abnormalities. Compr. Physiol. 4, 805 (2014).","journal-title":"Compr. Physiol."},{"key":"1276_CR116","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000450613","volume":"17","author":"J-S Kim","year":"2016","unstructured":"Kim, J.-S. et al. Arterial stiffness and cardiovascular autonomic dysfunction in patients with Parkinson\u2019s disease. Neurodegener. Dis. 17, 89\u201396 (2016).","journal-title":"Neurodegener. Dis."},{"key":"1276_CR117","doi-asserted-by":"publisher","first-page":"S374","DOI":"10.1002\/mds.21681","volume":"22","author":"W Poewe","year":"2007","unstructured":"Poewe, W. Dysautonomia and cognitive dysfunction in Parkinson\u2019s disease. Mov. Disord. 22, S374\u2013S378 (2007).","journal-title":"Mov. Disord."},{"key":"1276_CR118","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.parkreldis.2019.10.023","volume":"69","author":"CE Cicero","year":"2019","unstructured":"Cicero, C. E. et al. Cardiovascular autonomic function and MCI in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 69, 55\u201358 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1276_CR119","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1212\/WNL.0b013e31826c1acd","volume":"79","author":"J-S Kim","year":"2012","unstructured":"Kim, J.-S. et al. Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease. Neurology 79, 1323\u20131331 (2012).","journal-title":"Neurology"},{"key":"1276_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-15630-8","volume":"12","author":"K-Y Kwon","year":"2022","unstructured":"Kwon, K.-Y., Park, S., Kim, R. O., Lee, E. J. & Lee, M. Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson\u2019s disease. Sci. Rep. 12, 11461 (2022).","journal-title":"Sci. Rep."},{"key":"1276_CR121","doi-asserted-by":"publisher","first-page":"025016","DOI":"10.1088\/2057-1976\/abdf36","volume":"7","author":"T Tucker","year":"2021","unstructured":"Tucker, T. Arterial stiffness as a vascular contribution to cognitive impairment: a fluid dynamics perspective. Biomed. Phys. Eng. Express 7, 025016 (2021).","journal-title":"Biomed. Phys. Eng. Express"},{"key":"1276_CR122","doi-asserted-by":"publisher","DOI":"10.1177\/1756286419838354","volume":"12","author":"L Pelizzari","year":"2019","unstructured":"Pelizzari, L. et al. Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson\u2019s disease. Therapeutic Adv. Neurol. Disord. 12, 1756286419838354 (2019).","journal-title":"Therapeutic Adv. Neurol. Disord."},{"key":"1276_CR123","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1002\/jmri.25489","volume":"45","author":"K Yamashita","year":"2017","unstructured":"Yamashita, K. et al. Cerebral blood flow laterality derived from arterial spin labeling as a biomarker for assessing the disease severity of parkinson\u2019s disease. J. Magn. Reson. Imaging 45, 1821\u20131826 (2017).","journal-title":"J. Magn. Reson. Imaging"},{"key":"1276_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1219","volume":"9","author":"Y Wan","year":"2019","unstructured":"Wan, Y. et al. Exploring the association between Cerebral small-vessel diseases and motor symptoms in Parkinson\u2019s disease. Brain Behav. 9, e01219 (2019).","journal-title":"Brain Behav."},{"key":"1276_CR125","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1159\/000540639","volume":"54","author":"M Hosoya","year":"2024","unstructured":"Hosoya, M. et al. Motor function is associated with cerebral small vessel disease and can predict mortality and poor functional outcome. Cerebrovasc. Dis. 54, 489\u2013498 (2024).","journal-title":"Cerebrovasc. Dis."},{"key":"1276_CR126","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.773951","volume":"13","author":"X Ma","year":"2021","unstructured":"Ma, X. et al. Diffusion tensor imaging along the perivascular space index in different stages of Parkinson\u2019s disease. Front. Aging Neurosci. 13, 773951 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"1276_CR127","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1161\/STROKEAHA.111.623462","volume":"42","author":"AS Buchman","year":"2011","unstructured":"Buchman, A. S., Leurgans, S. E., Nag, S., Bennett, D. A. & Schneider, J. A. Cerebrovascular disease pathology and parkinsonian signs in old age. Stroke 42, 3183\u20133189 (2011).","journal-title":"Stroke"},{"key":"1276_CR128","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/mds.29496","volume":"38","author":"C Simonet","year":"2023","unstructured":"Simonet, C. et al. The emergence and progression of motor dysfunction in individuals at risk of Parkinson\u2019s disease. Mov. Disord. 38, 1636\u20131644 (2023).","journal-title":"Mov. Disord."},{"key":"1276_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-024-00570-4","volume":"21","author":"T Vikner","year":"2024","unstructured":"Vikner, T. et al. CSF dynamics throughout the ventricular system using 4D flow MRI: associations to arterial pulsatility, ventricular volumes, and age. Fluids Barriers CNS 21, 68 (2024).","journal-title":"Fluids Barriers CNS"},{"key":"1276_CR130","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1148\/radiology.209.3.9844657","volume":"209","author":"PC Buijs","year":"1998","unstructured":"Buijs, P. C. et al. Effect of age on cerebral blood flow: measurement with ungated two-dimensional phase-contrast MR angiography in 250 adults. Radiology 209, 667\u2013674 (1998).","journal-title":"Radiology"},{"key":"1276_CR131","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/jcbfm.2014.203","volume":"35","author":"S Amin-Hanjani","year":"2015","unstructured":"Amin-Hanjani, S., Du, X., Pandey, D. K., Thulborn, K. R. & Charbel, F. T. Effect of age and vascular anatomy on blood flow in major cerebral vessels. J. Cereb. Blood Flow. Metab. 35, 312\u2013318 (2015).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"1276_CR132","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1161\/01.STR.31.1.147","volume":"31","author":"P Scheel","year":"2000","unstructured":"Scheel, P., Ruge, C., Petruch, U. R. & Sch\u00f6ning, M. Color duplex measurement of cerebral blood flow volume in healthy adults. Stroke 31, 147\u2013150 (2000).","journal-title":"Stroke"},{"key":"1276_CR133","first-page":"1","volume":"0","author":"MR MacAskill","year":"2022","unstructured":"MacAskill, M. R. et al. The New Zealand Parkinson\u2019s progression programme. J. R. Soc. N.Z. 0, 1\u201323 (2022).","journal-title":"J. R. Soc. N.Z."},{"key":"1276_CR134","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes, A. J., Daniel, S. E., Kilford, L. & Lees, A. J. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55, 181\u2013184 (1992).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1276_CR135","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/mds.23592","volume":"26","author":"JC Dalrymple-Alford","year":"2011","unstructured":"Dalrymple-Alford, J. C. et al. Characterizing mild cognitive impairment in Parkinson\u2019s disease. Mov. Disord. 26, 629\u2013636 (2011).","journal-title":"Mov. Disord."},{"key":"1276_CR136","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre, M. et al. Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov. Disord. 22, 1689\u20131707 (2007).","journal-title":"Mov. Disord."},{"key":"1276_CR137","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine, Z. S. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatrics Soc. 53, 695\u2013699 (2005).","journal-title":"J. Am. Geriatrics Soc."},{"key":"1276_CR138","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","volume":"19","author":"CG Goetz","year":"2004","unstructured":"Goetz, C. G. et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations the Movement Disorder Society Task Force on rating scales for Parkinson\u2019s disease. Mov. Disord. 19, 1020\u20131028 (2004).","journal-title":"Mov. Disord."},{"key":"1276_CR139","doi-asserted-by":"crossref","unstructured":"Goetz, C. G. et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170 (2008).","DOI":"10.1002\/mds.22340"},{"key":"1276_CR140","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan, I. et al. Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease : movement disorder society task force guidelines methodology the MDS task force first reviewed literature on the current methods of defining MCI different criteria for def. Mov. Disord. 27, 349\u2013356 (2012).","journal-title":"Mov. Disord."},{"key":"1276_CR141","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0735-1097(01)01108-1","volume":"37","author":"AM Dart","year":"2001","unstructured":"Dart, A. M. & Kingwell, B. A. Pulse pressure\u2014a review of mechanisms and clinical relevance. J. Am. Coll. Cardiol. 37, 975\u2013984 (2001).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1276_CR142","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1161\/01.HYP.36.5.801","volume":"36","author":"HD Sesso","year":"2000","unstructured":"Sesso, H. D. et al. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men. Hypertension 36, 801\u2013807 (2000).","journal-title":"Hypertension"},{"key":"1276_CR143","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.tcm.2019.05.003","volume":"30","author":"JM Flack","year":"2020","unstructured":"Flack, J. M. & Adekola, B. Blood pressure and the new ACC\/AHA hypertension guidelines. Trends Cardiovasc. Med. 30, 160\u2013164 (2020).","journal-title":"Trends Cardiovasc. Med."},{"key":"1276_CR144","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.autneu.2011.02.004","volume":"161","author":"R Freeman","year":"2011","unstructured":"Freeman, R. et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Autonomic Neurosci. 161, 46\u201348 (2011).","journal-title":"Autonomic Neurosci."},{"key":"1276_CR145","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00415-016-8375-x","volume":"264","author":"CH Gibbons","year":"2017","unstructured":"Gibbons, C. H. et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension. J. Neurol. 264, 1567\u20131582 (2017).","journal-title":"J. Neurol."},{"key":"1276_CR146","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson, C. L. et al. Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov. Disord. 25, 2649\u20132653 (2010).","journal-title":"Mov. Disord."},{"key":"1276_CR147","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1002\/jmri.24900","volume":"42","author":"E Schrauben","year":"2015","unstructured":"Schrauben, E. et al. Fast 4D flow MRI intracranial segmentation and quantification in tortuous arteries: fast 4D flow processing tool. J. Magn. Reson. Imaging 42, 1458\u20131464 (2015).","journal-title":"J. Magn. Reson. Imaging"},{"key":"1276_CR148","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mri.2022.12.016","volume":"97","author":"GS Roberts","year":"2023","unstructured":"Roberts, G. S. et al. Automated hemodynamic assessment for cranial 4D flow MRI. Magn. Reson. Imaging 97, 46\u201355 (2023).","journal-title":"Magn. Reson. Imaging"},{"key":"1276_CR149","unstructured":"Sotelo, J., Mura, J., Hurtado, D. & Uribe, S. A novel MATLAB toolbox for processing 4D Flow MRI data. In International Society of Magnetic Resonance in Medicine (ISMRM) (ISMRM, 2019)."},{"key":"1276_CR150","first-page":"1770","volume":"27","author":"H Tanaka","year":"2006","unstructured":"Tanaka, H. et al. Relationship between variations in the circle of Willis and flow rates in internal carotid and basilar arteries determined by means of magnetic resonance imaging with semiautomated lumen segmentation: reference data from 125 healthy volunteers. Am. J. Neuroradiol. 27, 1770\u20131775 (2006).","journal-title":"Am. J. Neuroradiol."},{"key":"1276_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S Van Buuren","year":"2011","unstructured":"Van Buuren, S. & Groothuis-Oudshoorn, K. Mice: multivariate imputation by chained equations in R. J. Stat. Softw. 45, 1\u201367 (2011).","journal-title":"J. Stat. Softw."},{"key":"1276_CR152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v080.i01","volume":"80","author":"P-C B\u00fcrkner","year":"2017","unstructured":"B\u00fcrkner, P.-C. Brms: an R package for Bayesian multilevel models using Stan. J. Stat. Softw. 80, 1\u201328 (2017).","journal-title":"J. Stat. Softw."},{"key":"1276_CR153","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s11222-016-9696-4","volume":"27","author":"A Vehtari","year":"2017","unstructured":"Vehtari, A., Gelman, A. & Gabry, J. Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC. Stat. Comput. 27, 1413\u20131432 (2017).","journal-title":"Stat. Comput."},{"key":"1276_CR154","unstructured":"B\u00fcrkner, P.-C., Gabry, J., Kay, M. & Vehtari, A. Posterior: Tools for Working with Posterior Distributions. R package version 1, (2023)."},{"key":"1276_CR155","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/cpns.41","volume":"82","author":"RR Wilcox","year":"2018","unstructured":"Wilcox, R. R. & Rousselet, G. A. A guide to robust statistical methods in neuroscience. Curr. Protoc. Neurosci. 82, 8\u201342 (2018).","journal-title":"Curr. Protoc. Neurosci."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01276-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01276-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01276-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:03:54Z","timestamp":1774541034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01276-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":155,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1276"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01276-0","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}